Evidence is mounting that a group of AIDS-like retroviruses are to blame for chronic fatigue, a debilitating condition marked by loss of energy and other ailments, such as depression, memory or concentration impairment, muscle and joint pain and shortness of breath. As this link becomes more definitive, employers should prepare for a wave of new chronic fatigue diagnoses, and for a big jump in disability costs.
Studies show that as many as 1 million Americans (most working-age adults) have chronic fatigue, though only about one in five has been diagnosed. With no obvious cause for what has been defined as a "syndrome," doctors often don't diagnose it, attributing the symptoms to psychological issues.
The Social Security Administration, the courts and private disability insurers have granted disability claims in cases where there has been a chronic fatigue diagnosis, but attorneys specializing in disability cases say that the lack of a cause discouraged such claims, and made it easier for disability insurers to invoke the "subjective claim limitation" clause in disability policies, which generally limits employee disability payments to two years when no underlying cause can be found.
Complete your profile to continue reading and get FREE access to Treasury & Risk, part of your ALM digital membership.
Your access to unlimited Treasury & Risk content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical Treasury & Risk information including in-depth analysis of treasury and finance best practices, case studies with corporate innovators, informative newsletters, educational webcasts and videos, and resources from industry leaders.
- Exclusive discounts on ALM and Treasury & Risk events.
- Access to other award-winning ALM websites including PropertyCasualty360.com and Law.com.
*May exclude premium content
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
